Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. Scope of the Report: This report focuses on the Alzheimer?s Disease Drug in Europe market, especially in Germany, UK, France, Russia, and Italy. This report categorizes the market based on manufacturers, countries, type and application. Market Segment by Manufacturers, this report covers Allergan Eisai Novartis Daiichi Sankyo Merz Pharma Pfizer Johnson & Johnson Lundbeck. Market Segment by Countries, covering Germany UK France Russia Italy Market Segment by Type, covers Donepezil Memantine Rivastigmine Market Segment by Applications, can be divided into Early to Moderate Stages Moderate to Severe Stages There are 17 Chapters to deeply display the Europe Alzheimer?s Disease Drug market. Chapter 1, to describe Alzheimer?s Disease Drug Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Alzheimer?s Disease Drug, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers in Europe, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the Europe market by countries, covering Germany, UK, France, Italy and Russia, with sales, price, revenue and market share of Alzheimer?s Disease Drug, for each country, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type and application, from 2012 to 2017; Chapter 7, 8, 9, 10 and 11, to analyze the key countries by manufacturers, Type and Application, covering Germany, UK, France, Italy and Russia, with sales, revenue and market share by manufacturers, types and applications; Chapter 12, Alzheimer?s Disease Drug market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022; Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 15, to describe Alzheimer?s Disease Drug sales channel, distributors, traders, dealers etc. Chapter 16 and 17, to describe Alzheimer?s Disease Drug Research Findings and Conclusion, Appendix, methodology and data source
Table of Contents 1 Market Overview 1.1 Alzheimer?s Disease Drug Introduction 1.2 Market Analysis by Type 1.2.1 Donepezil 1.2.2 Memantine 1.2.3 Rivastigmine 1.3 Market Analysis by Applications 1.3.1 Early to Moderate Stages 1.3.2 Moderate to Severe Stages 1.4 Market Analysis by Countries 1.4.1 Germany Status and Prospect (2
